Monitoring
Patients should be followed up clinically as needed for response to therapy and to rule out emerging neurological deficits that may indicate an alternative underlying diagnosis.
Patients receiving botulinum toxin therapy are typically followed up every 3 months, while other patients with an established diagnosis can be followed up less frequently.
No ongoing laboratory testing, imaging, or physiological testing is routinely indicated.
Use of this content is subject to our disclaimer